# IgM-enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis

> **NCT02444871** · — · COMPLETED · sponsor: **Goethe University** · enrollment: 30 (actual)

## Conditions studied

- Sepsis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02444871
- **Lead sponsor:** Goethe University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02444871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02444871, "IgM-enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02444871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*